TRICALS
We appreciate TRICALS helping raise awareness of the initiation of our Phase 2 clinical study of RT001 in ALS in Europe. A special thank you to the world-class clinical investigators who are making this trial possible.
https://www.tricals.org/en/news/retrotope-announces-initiation-of-rt001-study-in-people-with-als/